Platinum Partners Value Arbitrage Fund, LP
10% Owner

Platinum Partners Value Arbitrage Fund, LP insider trades: Navidea Biopharmaceuticals (NAVB) stock buys and sales

10% Owner, Navidea Biopharmaceuticals Last trade Sep 2, 2014 11 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2009
5
Companies
last trade 2014

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Platinum Partners Value Arbitrage Fund, LP reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 2, 2014NAVB↓ Sell$82K
Jun 30, 2014ECTE↑ Buy$145K
Jun 26, 2014ECTE↑ Buy$38K
Jun 24, 2014ECTE↑ Buy$37K
Dec 10, 2013ECTE↑ Buy$153K
Dec 10, 2013ECTE↑ Buy$38K
Oct 10, 2012NAVB↑ Buy$95K
Sep 21, 2012NAVB↓ Sell$2.6M
Dec 28, 2010IFN↓ Sell$86.0M
Dec 27, 2010IFN↑ Buy$7.8M
Jan 15, 2009CHNQ.OB↓ Sell$2.3M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Platinum Partners Value Arbitrage Fund, LP's insider trades

Platinum Partners Value Arbitrage Fund, LP is a 10% owner of Navidea Biopharmaceuticals (NAVB). Since Jan 15, 2009, it has reported 7 open-market purchases worth $8.3M and 4 sales worth $91.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (5 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NAVB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.